Thromboelastography Machine Market - Size, Share, Outlook, and Forecast till 2026

Thromboelastography (TEG) is a method used for testing the efficiency of blood coagulation. This test is mainly used in surgery and anesthesiology. There are other tests for blood coagulation, which include prothrombin time (PT,INR) and partial thromboplastin time (aPTT). These tests are capable of measuring the coagulation factor function. However, by using TEG, platelet function, clot strength, and fibrinolysis can also be assessed. TEG machines are used for carrying out this test.

Get Sample copy of research report: https://www.worldwidemarketreports.com/sample/195640

The addition of TEG machines for blood management program will help in predicting and managing coagulopathy, help in assessing the risk for re-operation, and will lead to cost saving, as it reduces unnecessary blood component transfusions. These machines find applications in hospitals, blood banks, pharmaceutical, and academia.

Increasing prevalence of surgeries in various domains of healthcare is one of the major factors driving growth of thromboelastography machine market size. Rising interest in its clinical use in trauma resuscitation, particularly for managing acute coagulopathy of trauma and assisting decision making concerning transfusion is another factor that is expected to fuel growth of the market over the forecast period.

However, increasing number of research and development activities that might lead to the development of new methods for testing the efficiency of blood coagulation is expected to affect growth of thromboelastography machine market.

Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/195640

Key Developments in Thromboelastography Machine Market

Key players are adopting various strategies such as mergers, acquisitions, new product launches, expansions, collaborations, partnerships, approvals, and joint ventures to retain its position in the thromboelastography machine market. Haemonetics is one of the major players operating in the thromboelastography machine market.

TEG 5000 is a thromboelastograph hemostasis analyzer system manufactured by Haemonetics. It is a diagnostic instrument that helps in providing comprehensive whole blood hemostasis testing. Also, it helps in assessing bleeding and thrombotic risks, and also monitor antithrombotic therapies.

TEG 6s is another system by Haemonetics, which provides rapid, comprehensive and accurate identification of an individual’s hemostasis condition in a laboratory or point-of-care setting. Although TEG 6s delivers the same quality test results, it does not involve the complicated test preparation process. Moreover, it allows clinicians to drive personalized, clinically, and economically sound treatment and monitoring decisions with confidence.

About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703

This release was published on openPR.